Delivery Order SPE2DB22D3011-SPE2DB24FP8XC
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,187.60 firm fixed price delivery order contract from the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,781.40 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, in support of military treatment programs and facilities. The delivery order has a completion date of March 5, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $1,187.60 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product, with a potential value of $5,605.20. The delivery order has a completion date of February 23, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,528.00 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,647.62 firm fixed price delivery order by the Defense Logistics Agency (DLA) to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The delivery order has a completion date of January 29, 2024. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The contract has a potential value of $4,048.51 and a period of performance through January 31, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,268.25 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order contract has a performance period through February 14, 2024. Amerisourcebergen Drug Corp has previously been awarded an indefinite delivery contract (IDC) from DLA, which serves as the primary contract vehicle for the company...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,662.85 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen Drug Corp to supply a comprehensive range of medications and healthcare materials to military...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8XCDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. The contract has a potential value of $1,641.60 and a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/30/24 |